H L GENOMICS has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Republic of Korea, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are RECORDATI IND CHIMICA E FARMACEUTICA SPA, NANJING INNOCARE PHARMA TECH CO LTD and EIP PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 8 | |
#2 | China | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies | |
#5 | Organic chemistry methods | |
#6 | Microorganisms | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kim Hyun Gyu | 4 |
#2 | Lee Geun Hyeog | 3 |
#3 | Kwak Eun Young | 3 |
#4 | Ryu Jong Hyeon | 3 |
#5 | Kim Hyun-Gyu | 3 |
#6 | Park Jin Ha | 3 |
#7 | Lee Seo-Jin | 3 |
#8 | Lee Seo Jin | 2 |
#9 | Cho Mi La | 2 |
#10 | Ha Mun Choun | 2 |
Publication | Filing date | Title |
---|---|---|
KR101127814B1 | Novel intermediate and process for preparing sildenafil or its salt using the same | |
KR20110134249A | Process for preparing intermediate of pitavastatin or its salt | |
KR20110137588A | Pharmaceutical composition for preventing or treating obesity comprising vitis vinifera pip extract | |
KR100995882B1 | Process for preparing intermediate of pitavastatin or its salt | |
KR20110049627A | Pharmaceutical composition for preventing or treating gastrointestinal ulcer comprising vitis vinifera pip extract | |
KR20100053029A | Pharmaceutical composition for treating fibromyalgia syndrome or alleviating symptoms thereof comprising vitis vinifera pip extract | |
KR20090129079A | Process for preparing optically pure s-(-)-amlodipine benzensulfonate | |
KR20040012229A | Fibrinolytic enzyme derived from Bacillus sp. HLN-21 strain and, isolation and purification method thereof |